Traveller exposures to animals: a GeoSentinel analysis.


Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
09 11 2020
Historique:
received: 19 12 2019
revised: 21 01 2020
accepted: 23 01 2020
pubmed: 30 1 2020
medline: 29 7 2021
entrez: 30 1 2020
Statut: ppublish

Résumé

Human coexistence with other animals can result in both intentional and unintentional contact with a variety of mammalian and non-mammalian species. International travellers are at risk for such encounters; travellers risk injury, infection and possibly death from domestic and wild animal bites, scratches, licks and other exposures. The aim of the present analysis was to understand the diversity and distribution of animal-related exposures among international travellers. Data from January 2007 through December 2018 from the GeoSentinel Surveillance Network were reviewed. Records were included if the exposure was non-migration travel with a diagnosis of an animal (dog, cat, monkey, snake or other) bite or other exposure (non-bite); records were excluded if the region of exposure was not ascertainable or if another, unrelated acute diagnosis was reported. A total of 6470 animal exposures (bite or non-bite) were included. The majority (71%) occurred in Asia. Travellers to 167 countries had at least one report of an animal bite or non-bite exposure. The majority (76%) involved dogs, monkeys and cats, although a wide range of wild and domestic species were involved. Almost two-thirds (62.6%) of 4395 travellers with information available did not report a pretravel consultation with a healthcare provider. Minimizing bites and other animal exposures requires education (particularly during pretravel consultations) and behavioral modification. These should be supplemented by the use of pre-exposure rabies vaccination for travellers to high-risk countries (especially to those with limited access to rabies immunoglobulin), as well as encouragement of timely (in-country) post-exposure prophylaxis for rabies and Macacine alphaherpesvirus 1 (herpesvirus B) when warranted.

Sections du résumé

BACKGROUND
Human coexistence with other animals can result in both intentional and unintentional contact with a variety of mammalian and non-mammalian species. International travellers are at risk for such encounters; travellers risk injury, infection and possibly death from domestic and wild animal bites, scratches, licks and other exposures. The aim of the present analysis was to understand the diversity and distribution of animal-related exposures among international travellers.
METHODS
Data from January 2007 through December 2018 from the GeoSentinel Surveillance Network were reviewed. Records were included if the exposure was non-migration travel with a diagnosis of an animal (dog, cat, monkey, snake or other) bite or other exposure (non-bite); records were excluded if the region of exposure was not ascertainable or if another, unrelated acute diagnosis was reported.
RESULTS
A total of 6470 animal exposures (bite or non-bite) were included. The majority (71%) occurred in Asia. Travellers to 167 countries had at least one report of an animal bite or non-bite exposure. The majority (76%) involved dogs, monkeys and cats, although a wide range of wild and domestic species were involved. Almost two-thirds (62.6%) of 4395 travellers with information available did not report a pretravel consultation with a healthcare provider.
CONCLUSIONS
Minimizing bites and other animal exposures requires education (particularly during pretravel consultations) and behavioral modification. These should be supplemented by the use of pre-exposure rabies vaccination for travellers to high-risk countries (especially to those with limited access to rabies immunoglobulin), as well as encouragement of timely (in-country) post-exposure prophylaxis for rabies and Macacine alphaherpesvirus 1 (herpesvirus B) when warranted.

Identifiants

pubmed: 31993666
pii: 5716751
doi: 10.1093/jtm/taaa010
pmc: PMC7384971
mid: NIHMS1589816
pii:
doi:

Substances chimiques

Rabies Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : Medical Research Council
ID : G0701652
Pays : United Kingdom
Organisme : NCEZID CDC HHS
ID : U50 CK000189
Pays : United States

Investigateurs

Henry Wu (H)
Jesse Waggoner (J)
Watcharapong Piyaphanee (W)
Udomsak Silachamroon (U)
Christina Coyle (C)
Eli Schwartz (E)
Lucille Blumberg (L)
Albie de Frey (A)
Hugo Siu (H)
Luis Manuel Valdez (LM)
Michael Beadsworth (M)
Nicholas Beeching (N)
Michael Libman (M)
Cedric Yansouni (C)
Anne McCarthy (A)
Mauro Saio (M)
Marta Diaz Menendez (M)
Sabine Jordon (S)
Christof Vinnemeier (C)
Hilmer Ásgeirsson (H)
Hedvig Glans (H)
Natasha Hochberg (N)
Federico Gobbi (F)
Andrea Rossanese (A)
Effrossyni Gkrania-Klotsa (E)
Bradley Connor (B)
Perry van Genderen (P)
Susan Anderson (S)
Carmelo Licitra (C)
Ashley Thomas (A)
Lian Lim Poh (LL)
Christian Wejse (C)
Sanne Jespersen (S)
Frank Mockenhaupt (F)
Gundel Harms-Zwingenberger (G)
Paul Kelly (P)
Phi Truong Hoang Phu (PTH)
Jasper Chan (J)
Kwok-Yung Yuen (KY)
Johnnie Yates (J)
Victoria Johnston (V)
Vanessa Field (V)
Claudio Viscoli (C)
Federica Toscanini (F)
Prativa Pandey (P)
Bhawana Amatya (B)
Kunjana Mavunda (K)
Dorothy Contiguglia-Akcan (D)
Karin Leder (K)
Joe Torresi (J)
Jonathan Alpern (J)
Bill Stauffer (B)
Frank von Sonnenburg (F)
Camilla Rothe (C)
Stefan Hagmann (S)
Sunil Sood (S)
Ben Wyler (B)
John Cahill (J)
Eric Caumes (E)
Katherine Plewes (K)
Wayne Ghesquiere (W)
Daniel Leung (D)

Informations de copyright

© International Society of Travel Medicine 2020. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Références

Am J Trop Med Hyg. 2014 Feb;90(2):263-4
pubmed: 24297813
J Travel Med. 2003 Nov-Dec;10(6):340-5
pubmed: 14642201
Wilderness Environ Med. 2014 Jun;25(2):220-30
pubmed: 24864068
Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):12-6
pubmed: 18342268
J Travel Med. 2014 Jul-Aug;21(4):240-7
pubmed: 24845015
J Travel Med. 2009 Jul-Aug;16(4):229-32
pubmed: 19674260
Emerg Infect Dis. 2018 Feb;24(2):345-351
pubmed: 29350146
Vaccine. 2007 Mar 30;25(14):2656-63
pubmed: 17234310
PLoS Negl Trop Dis. 2012;6(9):e1852
pubmed: 23029598
Vaccine. 2012 Jan 5;30(2):126-33
pubmed: 22085557
MMWR Surveill Summ. 2013 Jul 19;62:1-23
pubmed: 23863769
Emerg Infect Dis. 2003 Feb;9(2):246-50
pubmed: 12603998
J Travel Med. 2019 May 10;26(3):
pubmed: 30924855
J Travel Med. 2005 Apr;12 Suppl 1:S30-40
pubmed: 16225804
Clin Infect Dis. 1995 Feb;20(2):421-39
pubmed: 7742451
Hum Brain Mapp. 2013 Apr;34(4):914-22
pubmed: 22125232
Am J Primatol. 2008 Sep;70(9):879-83
pubmed: 18521871
Emerg Infect Dis. 2002 Aug;8(8):789-95
pubmed: 12141963
Am J Phys Anthropol. 2017 Jan;162 Suppl 63:32-43
pubmed: 28105720
Travel Med Infect Dis. 2006 Sep;4(5):270-4
pubmed: 16905457
PLoS Negl Trop Dis. 2018 Nov 13;12(11):e0006951
pubmed: 30422981
Neth J Med. 2015 Jun;73(5):219-26
pubmed: 26087801
PLoS Negl Trop Dis. 2013 May 02;7(5):e2209
pubmed: 23658853
Wilderness Environ Med. 2005 Summer;16(2):67-74
pubmed: 15974255
J Travel Med. 1999 Sep;6(3):163-7
pubmed: 10467152
J Travel Med. 2015 Nov-Dec;22(6):403-9
pubmed: 26420372
Clin Microbiol Rev. 2011 Apr;24(2):231-46
pubmed: 21482724
J Travel Med. 2012 Sep-Oct;19(5):277-80
pubmed: 22943265
Med J Aust. 2011 Dec 19;195(11-12):673-5
pubmed: 22171863
MMWR Recomm Rep. 2008 May 23;57(RR-3):1-28
pubmed: 18496505
Am J Primatol. 2005 Jun;66(2):197-204
pubmed: 15940713

Auteurs

Michael P Muehlenbein (MP)

Department of Anthropology, Baylor University, 1214 S 4th St, Waco, TX 76706, USA.

Kristina M Angelo (KM)

Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, Georgia, 30333, USA.

Patricia Schlagenhauf (P)

WHO Collaborating Centre for Travellers' Health University of Zurich, Zurich, Switzerland, Department of Public and Global Health Hirschengraben 84, 8001 Zürich, Switzerland.

Lin Chen (L)

Department of Medicine, Mount Auburn Hospital, 330 Mount Auburn Street, Cambridge, Massachusetts, 02138, USA.

Martin P Grobusch (MP)

Department of Infectious Diseases, Division of Internal MEdicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, PO Box 22660, Amsterdam, Netherlands 1100DD.

Philippe Gautret (P)

Méditerranée Infection Foundation, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.

Alexandre Duvignaud (A)

Department of Infectious Diseases and Tropical Medicine , Division of Tropical Medicine and Clinical International Health, Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin, Place Amélie Raba Léon, 33076, Bordeaux, France.

François Chappuis (F)

Department of Primary Care Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland.

Kevin C Kain (KC)

Department of Medicine, University of Toronto, Toronto General Hospital, MaRS Centre, 101 College St, TMDT 10-360A, Ontario, Canada M5G1L7.

Emmanuel Bottieau (E)

Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium.

Loïc Epelboin (L)

Unité des Maladies Infectieuses et Tropicales, Centre Hospitalier Andree Rosemon, Ave des Flamboyants, 97300 Cayenne, French Guiana.

Marc Shaw (M)

Department of Tropical Medicine and Rehabilitation Services, James Cook University, 1 James Cook Drive, Townsville, Queensland 4811, Australia.

Noreen Hynes (N)

Division of Infectious Diseases, Department of Medicine, John Hopkins University School of Medicine, 1830 E Monument St, Suite 419, Baltimore, Maryland, 21205, USA.

Davidson H Hamer (DH)

Department of Global Health, Boston University School of Public Health, Crosstown 3rd floor, 801 Massachusetts Ave, Boston, Massachusetts, 02118, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH